Friday, April 26, 2024 3:48:45 PM
In BIELworld, I think Ilfeld will announce results of his opioid pilot study soon, and that is an important catalyst for BIEL because they have no other clinical proof that their device reduces opioid use. BIEL investors are pinning their hopes and dreams on the NOPAIN Act but at this moment BIEL is on the sidelines looking in.
And on FB the band plays on. The newest pumper thinks BIEL should increase the price of the ActiPatch to $99, contrary to the Law of Supply and Demand, the most basic tenet of every economist everywhere. Ahhh but what do economists know. This new pumper also thinks BIEL should sue the maker of the Assisi Loop and take over that market, and also offered to lend the company money if they would manipulate the share price for him. Gotta love the energy, I guess.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM